US Patent 7879991 CGRP binding nucleic acids

Patent 7879991 was granted and assigned to Noxxon Pharma on February, 2011 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Noxxon Pharma

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7879991

Date of Patent

February 1, 2011

Patent Application Number

10513490

Date Filed

May 6, 2003

Patent Citations Received

‌

US Patent 12122821 Regulation of glucose metabolism using anti-CGRP antibodies

Patent Primary Examiner

‌

Kimberly Chong

Patent abstract

The invention relates to an antagonist for CGRP and amylin, whereby the antagonist is a nucleic acid and said nucleic acid binds to CGRP or amylin. Said nucleic acid preferably comprises an L-nucleotide.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7879991 CGRP binding nucleic acids

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API